Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study
Cadonilimab,一种PD-1/CTLA-4双特异性抗体,用于治疗不可切除的肝细胞癌:一项真实世界研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04038-8
Wang, Yilin; Pan, Shida; Tian, Jiahe; Wang, Jianing; Yu, Yingying; Wang, Siyu; Li, Fengyi; Yang, Luo; Liu, Xiaomeng; Shen, Yingjuan; Qiu, Qin; Luan, Junqing; Jia, Mengdie; Xiong, Chuyue; Duan, Xuanxuan; Wang, Fu-Sheng; Meng, Fanping